Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

HALOHALO
17 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in HALOZYME THERAPEUTICS INC

No. Driehaus Capital Management exited its HALO (Halozyme Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 331,703 shares worth $12.3M. Driehaus Capital Management first reported HALO in Q1 2020 and held it in 16 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.3M

Total Shares Change

-239,531

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$40.68
0
2023-Q4
Decreased
331,703
-36.3%
$12.3M0.1%$36.96
0
2023-Q3
Increased
520,776
+0.3%
$19.9M0.3%$38.20
34
2023-Q2
Increased
518,957
+3.6%
$18.7M0.2%$36.07
35
2023-Q1
Decreased
500,660
-62.7%
$19.1M0.3%$38.19
0
2022-Q4
Decreased
1.3M
-0.3%
$76.4M1.1%$56.90
0
2022-Q3
Increased
1.3M
+5.0%
$53.2M0.8%$39.54
43
2022-Q2
Increased
1.3M
+51.9%
$56.4M0.9%$44.00
58
2022-Q1
Increased
844,063
+44.3%
$33.7M0.4%$39.88
47
2021-Q4
Decreased
584,910
-29.6%
$23.5M0.2%$40.21
0
2021-Q3
Increased
831,094
+46.7%
$33.8M0.4%$40.68
47
2021-Q2
Increased
566,459
+24.5%
$25.7M0.3%$45.41
42
2021-Q1
Increased
455,013
+59.7%
$19M0.3%$41.69
49
2020-Q4
Increased
284,946
+8.0%
$12.2M0.2%$42.71
36
2020-Q3
Increased
263,847
+6.8%
$6.9M0.1%$26.28
35
2020-Q2
Increased
247,032
+3.1%
$6.6M0.2%$26.81
34
2020-Q1
New
239,531
-
$4.3M0.1%$17.99
44

Other major holders of HALO: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used